🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2 study of oral dacomitinib given every 12 hours over days ...
Status
Completed
Location
Tower Hematology Oncology Medical Group
Start Date
2013-07
Trial ID
NCT01858389
Treatments Being Tested
This is a study to assess how much of the investigational drug, PF-00298804...
Status
Completed
Location
Princess Margaret Hospital
Start Date
2011-12
Trial ID
NCT01484847
Treatments Being Tested
This is an open label, monocentric, uncontrolled phase II trial with Dacomi...
Status
Unknown
Location
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Start Date
2014-11
Trial ID
NCT02268747
Treatments Being Tested
The study will determine if bioequivalence can be claimed between the propo...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-04
Trial ID
NCT01313793
Treatments Being Tested
Epidermal growth factor receptor (EGFR) is often over-expressed, and have b...
Status
Completed
Location
Severance Hospital
Start Date
2011-10
Trial ID
NCT01449201
Treatments Being Tested
This is a multicenter, open label, Phase I/IIB study investigating the effi...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2022-10-13
Trial ID
NCT05271916
Treatments Being Tested
This is a multinational, multicenter, randomized, open-label, Phase 3 study...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-09
Trial ID
NCT01774721
Treatments Being Tested
This is single dose study of radiolabeled \[14C\]PF-00299804 in healthy mal...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-01
Trial ID
NCT01034748
Treatments Being Tested
Study of a drug drug interaction between Paroxetine and PF-00299804....
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-03
Trial ID
NCT01318031
Research in test tubes suggests that may affect cytochrome P450 2D6 (CYP2D6...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-09
Trial ID
NCT00728468
Treatments Being Tested